Vivos (RDGL) Share-based Compensation (2010 - 2025)
Vivos (RDGL) reported Share-based Compensation of $22687.0 for Q4 2025, up 16.16% on a YoY basis from $19530.0 in Q4 2024, and up 112.27% sequentially from $10688.0 in Q3 2025.
Vivos (RDGL) Share-based Compensation (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 13 years of Share-based Compensation data on file, last reported at $22687.0 in Q4 2025.
- For the quarter ending Q4 2025, Share-based Compensation rose 16.16% year-over-year to $22687.0; the trailing twelve-month figure through Dec 2025 stood at $42750.0 (down 51.93% YoY), and the FY2025 full-year result was $42750.0, down 51.93% from the prior year.
- Share-based Compensation grew to $22687.0 in Q4 2025, from $10688.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $56163.0 in Q3 2024 to a low of -$4580.0 in Q3 2022.
- A 4-year average of $10282.5 and a median of $4687.0 in 2025 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation jumped 378.36% in 2022 and sank 80.97% in 2025, its largest moves.
- Tracing RDGL's Share-based Compensation over 4 years: stood at -$952.0 in 2021, then jumped by 378.36% to $2650.0 in 2022, then surged by 636.98% to $19530.0 in 2024, then gained by 16.16% to $22687.0 in 2025.
- Business Quant data shows RDGL's Share-based Compensation at $22687.0 in Q4 2025, $10688.0 in Q3 2025, and $4687.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Vivos | 27.30 Mn | 25.74 Mn | -3,105.00 | 22,687.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22,687.00 |
| Dec 31, 2025 | 22,687.00 |
| Sep 30, 2025 | 10,688.00 |
| Sep 30, 2025 | 10,688.00 |
| Jun 30, 2025 | 4,687.00 |
| Jun 30, 2025 | 4,687.00 |
| Mar 31, 2025 | 4,688.00 |
| Mar 31, 2025 | 4,688.00 |
| Dec 31, 2024 | 19,530.00 |
| Dec 31, 2024 | 19,530.00 |
| Sep 30, 2024 | 56,163.00 |
| Sep 30, 2024 | 56,163.00 |
| Jun 30, 2024 | 3,750.00 |
| Jun 30, 2024 | 3,750.00 |
| Mar 31, 2024 | 9,482.00 |
| Mar 31, 2024 | 9,482.00 |
| Dec 31, 2022 | 2,650.00 |
| Dec 31, 2022 | 2,650.00 |
| Sep 30, 2022 | -4,580.00 |
| Sep 30, 2022 | -4,580.00 |